2026-08-04
Detecting Counterfeit or Adulterated Research-Grade Peptides
Common adulteration methods (bulking agents, cheaper peptide subs), HPLC/MS detection, what COA-shopping looks like
EU REACH Compliance and Research Chemical Imports — 2026 Update
Registration thresholds, substance restrictions relevant to research supply, importer vs manufacturer obligations
Read the full piece →More from Research Chem Today
2026-07-31
China GMP Audits on the Rise — What It Means for Peptide Research Supply
NMPA enforcement trends, how they affect WHO-GMP claims from Chinese suppliers, what buyers should verify
2026-07-28
ISO/IEC 17025 Lab Accreditation — What It Actually Certifies
Difference from ISO 9001, scope of accreditation, how to read a third-party lab's cert
2026-07-21
USP Revision Watch — Sterility and Endotoxin Testing Updates
What pending/recent USP <71>/<85> revisions mean for research supply documentation
2026-07-17
Domestic vs Overseas Turnaround Times for Research Supply — Real Data
Shipping data from US vs China vs India suppliers; customs hold risk; lead-time variability by season
2026-07-07
Domestic vs Overseas Peptide Suppliers: The 2026 Buyer Risk Analysis
A supply-chain risk analysis of domestic vs overseas research peptide suppliers in 2026: customs seizure, transit degradation, processor stability.
2026-07-04
Sourcing Research Peptides and Bacteriostatic Water in the US: A 2026 Buyer's Guide
The 2026 supply-chain case for domestic, per-lot-COA sourcing of research peptides and bacteriostatic water — customs risk, documentation, and processor stability.
2026-07-03
Per-Lot COA Is Becoming Table Stakes — The Supplier Shakeout
Buyers now demand per-lot documentation; contrast vendors that publish it (e.g. BAC Water Depot) with those receiving warning letters
2026-06-30
FDA Warning Letters to Compounders — 2026 Pattern Roundup
Recurring citations (sterility, data integrity, BUD), what they signal about supply quality
2026-06-23
Quality Arbitrage in International Peptide Manufacturing — China and India
Quality arbitrage in international peptide manufacturing — how to read Chinese and Indian supplier capability, CoA forgery patterns, and what differentiates a credible source.
2026-06-16
Customs Seizure Patterns for Research Peptide Imports — A 2026 Pattern Read
Patterns in 2026 customs seizures of research peptide imports — categories, port-of-entry concentrations, manifest issues, and what the trend signals for domestic supply demand.
2026-06-09
USP General Chapter Revisions in 2026 That Affect Research Supply
Active USP General Chapter revisions in the 2026 Pharmacopeial Forum cycle that affect research-supply vendors — proposed changes, likely landing dates, and compliance lead time.
2026-06-04
FDA Warning Letters in 2026 — The Compounding Pharmacy Patterns
Analysis of 2026 FDA warning letters to compounding pharmacies — recurring deficiency categories, citation patterns, and implications for research-supply vendors operating alongside compounded products.
2026-06-04
Per-Lot CoA Adoption Is Becoming the Trust Floor in Research Chemical Supply
A working pattern across small US research suppliers: per-lot Certificates of Analysis published at a public URL are emerging as the de-facto trust floor below which buyers will not transact. A short read on why this matters for industry positioning.
What we cover
- FDA warning letters to research chemical suppliers
- Federal Register notices on bacteriostatic water and excipients
- USP General Chapter updates
- DEA scheduling changes affecting research supply
- Compounding pharmacy regulatory news
- International supply chain (China, India peptide manufacturing)
- Customs seizures and import policy
- Trade association positions (PCCA, IACP, IPEC)